Testing effectiveness (Phase 2)Ended earlyNCT04059094
What this trial is testing
A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - BALANCE - CF™1
Who this might be right for
Cystic Fibrosis
Boehringer Ingelheim 52